Agilent Technologies (A) Completes Acquisition of Proscia
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Agilent Technologies completed its acquisition of digital-pathology software provider Proscia for $240 million in cash at closing, with up to $30 million more contingent on future performance milestones. The deal, announced earlier and now closed, adds Proscia's clinical and life-sciences digital pathology platform to Agilent's portfolio. Agilent, based in Santa Clara, California, funded the purchase in cash. The acquisition expands Agilent's diagnostics and lab instrumentation offerings into digital pathology software. Investors will watch whether Proscia hits the milestone targets that would trigger the additional $30 million payout.
Muhabbit's AI wrote this summary in its own words from Business Wire's report. It can get details wrong, so check the source.
Named in this story
Proscia, Agilent Technologies (A)
A linked name opens that asset's sentiment page.